Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 9

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 9
---
angement Resolution be approved by Shareholders at the Special Meeting. Accordingly, we are seeking approval of the Arrangement Resolution by the affirmative vote of not less than (i) 66⁄% of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special Meeting, and (ii) a simple majority of the votes attached to Common Shares held by Shareholders
present in person (virtually) or represented by proxy at the Special Meeting excluding for this purpose votes attached to Common Shares held by persons described in items (a) through (d) of section 8.1(2) of Multilateral Instrument 61-101 —Protection of Minority Security Holders in Special Transactions (“MI 61-101”), which excludes Common Shares held by
related parties that are receiving a “collateral benefit” (as defined in MI 61-101) in connection with the transaction. See “Canadian Securities Law Matters—Multilateral Instrument 61-101” for more information.

We are also seeking approval of (i) the Compensation Resolution by the affirmative vote of a majority of the votes cast by Shareholders
present or represented by proxy at the Special Meeting, (ii) the Liquidation Resolution by the affirmative vote of not less than 66⁄% of the votes cast by
Shareholders present in person (virtually) or represented by proxy at the Special Meeting, and (iii) the Liquidator Resolution by the affirmative vote of not

2

less than 66⁄% of the votes cast by Shareholders present in person (virtually) or represented by proxy at
the Special Meeting. The Board unanimously recommends that Shareholders vote FOR the Compensation Resolution, FOR the Liquidation Resolution and FOR the Liquidator Resolution. The completion of the Arrangement is not conditional
upon the approval of the Compensation Resolution, the Liquidation Resolution or the Liquidator Resolution.

Pursuant to the Interim Order,
the record date for determining the Shareholders entitled to receive notice of and to vote at the Special Meeting is the close of business on November 21, 2025 (the “Record Date”). Only Shareholders whose names have been
entered in the applicable securities register as of the close of business on the Record Date are entitled to receive notice of and to vote at the Special Meeting.

Your vote is important regardless of the number of Common Shares you own. Shareholders are cordially invited to attend the Special
Meeting. Whether or not you plan to attend the Special Meeting, it